Initial Experience with Sildenafil, Bosentan, and Nitric Oxide for Pediatric Cardiomyopathy Patients with Elevated Pulmonary Vascular Resistance before and after Orthotopic Heart Transplantation
Background. Although pulmonary hypertension complicating dilated cardiomyopathy has been shown to be a significant risk factor for graft failure after heart transplantation, the upper limits of pulmonary vascular resistance (PVR) that would contraindicate pediatric heart transplantation are not know...
Saved in:
Main Authors: | Babak Daftari, Juan Carlos Alejos, Gregory Perens |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Journal of Transplantation |
Online Access: | http://dx.doi.org/10.1155/2010/656984 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Addition of Sildenafil in Patients with Pulmonary Arterial Hypertension with Inadequate Response to Bosentan Monotherapy
by: Nancy R Porhownik, et al.
Published: (2008-01-01) -
Study on the comparison between Bosentan and Macitentan in the treatment of persistent pulmonary hypertension of the newborns, simultaneously on sildenafil: A randomized double-blinded non-inferiority parallel clinical trial
by: Mandana Kashaki, et al.
Published: (2025-01-01) -
The Successful Use of Inhaled Nitric Oxide in the Management of Severe Hepatopulmonary Syndrome after Orthotopic Liver Transplantation
by: Joshua Santos, et al.
Published: (2014-01-01) -
3D bioprinting lobule-like hepatorganoids with induced vascularization for orthotopic implantation
by: Jianing Yan, et al.
Published: (2025-04-01) -
Changes in Retinal and Choroidal Vascular Blood Flow after Oral Sildenafil: An Optical Coherence Tomography Angiography Study
by: David Berrones, et al.
Published: (2017-01-01)